Eli Lilly and Company (LLY) vs Platinum Futures (PLATINUM)
See how Eli Lilly and Company and Platinum Futures differ across market data and performance, so you can decide which asset best fits your strategy.
$1,156.73
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page$1,771.1
NY Mercantile
Platinum Futures represent standardized exchange-traded contracts linked to the future price of platinum. They are used by producers, consumers, traders, and investors to hedge exposure, express views on supply and demand, or gain commodity-market exposure. Their price is influenced by auto-catalyst demand, jewelry demand, industrial use, mine supply, investor flows, and the U.S. dollar.
View Full PageKey Metrics Comparison
Eli Lilly and CompanyLLY
Market Cap$1.032T
Price$1,156.73
24h Change-1.52%
24h Volume$3.03M
Employees50,000
Shares Outstanding944,818,881
Platinum FuturesPLATINUM
Market Cap$442.775B
Price$1,771.1
24h Change-1.29%
24h Volume$5.3K
EmployeesN/A
Shares OutstandingN/A
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
LLY
70.0%PLATINUM
30.0%Volume Share
Share of combined 24h volume
LLY
99.8%PLATINUM
1.0%24h Performance
Price change over last 24 hours
LLY
-1.52%PLATINUM
-1.29%Price Comparison
Eli Lilly and Company
Platinum Futures